Skip to main content
. 2026 May 25;12(3):e147. doi: 10.1192/bjo.2026.12001

Table 4.

Meta-analysis results of adverse events

Outcome Meta-analysis Heterogeneity Certainty
Risk ratio (95% CI) p-value τ 2 Prediction interval
Abdominal pain 2.93 (1.13–7.6) 0.027 0 1.13–7.60 High
Constipation 3.23 (1.14–9.18) 0.028 0.38 0.65–16.03 Moderate
Diarrhoea 1.5 (0.69–3.24) 0.308 0.14 0.52–4.34 Low
Nausea 1.44 (0.87–2.39) 0.152 0.08 0.69–3.02 Low
Serious adverse event 0.81 (0.52–1.26) 0.345 0 0.52–1.26 Low
Vomiting 2.57 (1.39–4.77) 0.003 0 1.39–4.77 High